These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 4096357

  • 1. [Transdermal scopolamine (TTS-scopolamine) for the prevention of postoperative nausea and vomiting].
    Tolksdorf W, Meisel R, Müller P, Bender HJ.
    Anaesthesist; 1985 Dec; 34(12):656-62. PubMed ID: 4096357
    [Abstract] [Full Text] [Related]

  • 2. [Effects and side effects of transdermal scopolamine for premedication in general anesthesia in elderly patients].
    Tolksdorf W, Baumann S, Heine C, Hettenbach A.
    Anasth Intensivther Notfallmed; 1986 Dec; 21(6):301-6. PubMed ID: 3544938
    [Abstract] [Full Text] [Related]

  • 3. [Transdermal scopolamine or droperidol in the prevention of postoperative nausea and vomiting in cholecystectomy patients].
    Schuh R, Tolksdorf W, Hucke H.
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):261-6. PubMed ID: 3326423
    [Abstract] [Full Text] [Related]

  • 4. [Transdermal scopolamine for postoperative vomiting: a new form of premedication?].
    Waldvogel HH.
    Anasth Intensivther Notfallmed; 1983 Oct; 18(5):258-60. PubMed ID: 6660442
    [Abstract] [Full Text] [Related]

  • 5. [Transdermal scopolamine to prevent postoperative nausea and vomiting after uterine curettage and termination of pregnancy. A double-blind clinically controlled study with placebo].
    Jespersen TW, Koch J, Anker-Møller E, Spangsberg NL, Johansen UT, Grydehøj P.
    Ugeskr Laeger; 1989 May 15; 151(20):1246-8. PubMed ID: 2660376
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of transdermal scopolamine, droperidol and placebo against postoperative nausea and vomiting.
    Tigerstedt I, Salmela L, Aromaa U.
    Acta Anaesthesiol Scand; 1988 Aug 15; 32(6):454-7. PubMed ID: 3051839
    [Abstract] [Full Text] [Related]

  • 7. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z, Shupak A, Gordon CR.
    Clin Pharmacokinet; 2006 Aug 15; 45(6):543-66. PubMed ID: 16719539
    [Abstract] [Full Text] [Related]

  • 8. Preoperative transdermal hyoscine for the prevention of postoperative nausea and vomiting.
    Wilkinson AR, Frampton CM, Glover PW, Davis FM.
    Anaesth Intensive Care; 1989 Aug 15; 17(3):285-9. PubMed ID: 2774147
    [Abstract] [Full Text] [Related]

  • 9. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy.
    Bailey PL, Streisand JB, Pace NL, Bubbers SJ, East KA, Mulder S, Stanley TH.
    Anesthesiology; 1990 Jun 15; 72(6):977-80. PubMed ID: 2140929
    [Abstract] [Full Text] [Related]

  • 10. Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas.
    van Marion WF, Bongaerts MC, Christiaanse JC, Hofkamp HG, van Ouwerkerk W.
    Clin Pharmacol Ther; 1985 Sep 15; 38(3):301-5. PubMed ID: 4028625
    [Abstract] [Full Text] [Related]

  • 11. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy.
    Sohi HS, Heipel J, Inman KJ, Chinnick B, Cunningham DG, Holliday RL, Girotti MJ.
    Can J Surg; 1994 Aug 15; 37(4):307-12. PubMed ID: 8055388
    [Abstract] [Full Text] [Related]

  • 12. Effects of atropine and scopolamine on bradycardia and emetic symptoms in otoplasty.
    Honkavaara P, Pyykkö I.
    Laryngoscope; 1999 Jan 15; 109(1):108-12. PubMed ID: 9917050
    [Abstract] [Full Text] [Related]

  • 13. Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting.
    Pergolizzi JV, Philip BK, Leslie JB, Taylor R, Raffa RB.
    J Clin Anesth; 2012 Jun 15; 24(4):334-45. PubMed ID: 22608591
    [Abstract] [Full Text] [Related]

  • 14. Effect of transdermal hyoscine on nausea and vomiting after surgical correction of prominent ears under general anaesthesia.
    Honkavaara P, Saarnivaara L, Klemola UM.
    Br J Anaesth; 1995 Jun 15; 74(6):647-50. PubMed ID: 7640117
    [Abstract] [Full Text] [Related]

  • 15. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
    Mantovani G, Curreli L, Macciò A, Massa E, Massa D, Mulas C, Succu G, Contu P.
    Anticancer Res; 1999 Jun 15; 19(4C):3495-502. PubMed ID: 10629642
    [Abstract] [Full Text] [Related]

  • 16. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct 15; 25(5):299-302, 319. PubMed ID: 2076342
    [Abstract] [Full Text] [Related]

  • 17. Transdermal hyoscine and postoperative nausea and vomiting.
    Uppington J, Dunnet J, Blogg CE.
    Anaesthesia; 1986 Jan 15; 41(1):16-20. PubMed ID: 3946771
    [Abstract] [Full Text] [Related]

  • 18. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study.
    Reinhart DJ, Klein KW, Schroff E.
    Anesth Analg; 1994 Aug 15; 79(2):281-4. PubMed ID: 7639364
    [Abstract] [Full Text] [Related]

  • 19. Effect of transdermal hyoscine on nausea and vomiting during and after middle ear surgery under local anaesthesia.
    Honkavaara P.
    Br J Anaesth; 1996 Jan 15; 76(1):49-53. PubMed ID: 8672379
    [Abstract] [Full Text] [Related]

  • 20. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G, Goossens H, Seemann K, Souchon F, Weitz T.
    Dtsch Med Wochenschr; 1984 Dec 07; 109(49):1881-5. PubMed ID: 6499689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.